ResidualPlaybeta Open the radar

The Therapist Impostor

Brady Medearis · 2026 · $4.99 · Adventure · deal grade B

Measured on 2026-09-24 08:27 UTC, 12 days ago. The whole catalog is re-measured daily; a game that just launched can move fast between passes.

  • Estimated net residual revenue: $335 to $502 per month
  • Opportunity: $795 per month at x1.90 dormancy
  • Estimated lifetime owners: 1.2k
  • 100% positive across 33 reviews · 10.0 reviews/month

Why it's flagged

  • No developer announcement on record, ever
  • Store page localized in only 1 language(s)

Analyst notes (AI-assisted)

Note written 2026-09-06; the live figures above take precedence over any numbers in it.

A short FMV adventure game where you roleplay as an impostor therapist, making dialogue choices with comedic consequences.

The Therapist Impostor sits in an underserved niche: low-commitment, choice-driven interactive fiction with genuine entertainment value and near-perfect player sentiment. The title has accumulated modest but durable residuals and shows strong review velocity relative to its tiny installed base, suggesting word-of-mouth traction within a specific audience (players seeking low-stimulation, narrative-light experiences). For a publisher seeking catalog depth in the indie adventure space or a developer building a therapy-comedy franchise, this represents a clear-eyed acquisition: small upside, negligible downside, and immediate fit into existing distribution channels. Most realistic play: acquisition.

  • Risk: Ultra-niche appeal (low-stimulation, comedy FMV) limits ceiling growth; player acquisition costs may exceed residual margins at scale.
  • Risk: Solo developer operation with no recent communication posts; rights consolidation and post-acquisition support roadmap are essential.
  • Risk: No cloud saves, achievements, or workshop integration; modernization pass required to compete for shelf space in 2026+.

This case as Markdown · Estimates carry ±30-50% error per title.